₨ 6,500.00
MBBS
TRAJENTA TABLET 5MG ( LINAGLIPTIN )
- Generic Name: linagliptin
- Manufactured by : Boehringer Ingelheim Limited
- Drug Strength : 5 mg
- Drug Form : Tablet
- Pack Size : 30 Tablets
- Product SKU : TYB_3056
Trajenta contains LINAGLIPTIN and is now available in Pakistan. The price of Trajenta is Rs.6500 as of 1st January 2025 it can be purchased online from MedicalStore.com.pk. The prices are updated regularly on this page.
TRAJENTA TABLET 5MG (LINAGLIPTIN)
TRAJENTA TABLET 5MG contains Linagliptin, which is used to treat type 2 diabetes by controlling blood sugar levels.
How It Works
Linagliptin belongs to the class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitors. It works by increasing the levels of incretin hormones in the body. These hormones help stimulate the pancreas to release insulin and reduce the amount of glucose produced by the liver.
Side Effects
-
- Nausea
- Headache
- Hypoglycemia (low blood sugar)
- Upper respiratory tract infection
- Joint pain
Indications
-
- Type 2 diabetes mellitus
Contraindications
-
- Type 1 diabetes
- Diabetic ketoacidosis
- Severe kidney problems
Top 5 Global Brands
- Brand A
- Brand B
- Brand C
- Brand D
- Brand E
How it works
TRAJENTA TABLET 5MG ( LINAGLIPTIN ) increases insulin and lowers glucagon production. This results in a reduction of the blood glucose levels.
Side effects
Major & minor side effects for TRAJENTA TABLET 5MG ( LINAGLIPTIN )
- Anxiety
- Blurred vision
- Confusion
- Depression
- Fast heartbeat
- Headache
- Nausea
- Increased hunger
- Slurred speech
- Chills
- Unusual tiredness or weakness
Uses of TRAJENTA TABLET 5MG ( LINAGLIPTIN )
What is it prescribed for?
-
Type II Diabetes Mellitus
This medicine reduces blood glucose levels in patients with type II diabetes mellitus.
When not to use?
-
Allergy
This medicine is not recommended for use in patients with a known allergy to TRAJENTA TABLET 5MG ( LINAGLIPTIN ) or any other inactive ingredients present along with it.
-
Type 1 Diabetes mellitus
This medicine is not recommended for use in patients with type 1 diabetes mellitus since it is not effective in treating this condition.
-
Diabetic ketoacidosis
This medicine is not recommended for use in patients with a known history of diabetic ketoacidosis due to the increased risk of worsening of the patient's condition.
-
Insulin secreagogues
This medicine should be used with caution in patients who are using insulin secretagogues due to the increased risk of hypoglycemia. Close monitoring of blood sugar levels is recommended for such patients. Appropriate dose adjustments may be necessary based on the clinical condition.
-
Bullous pemphigoid
This medicine should be used with caution due to the increased risk of bullous pemphigoid, a hypersensitivity reaction of the skin. Any unusual symptoms such as skin blisters or skin rashes should be reported to the doctor on priority. Therapy with the medicine may be discontinued based on the clinical condition of the patient.
-
Arthralgia
This medicine should be used with caution in patients with a known history of severe arthralgia due to the increased risk of worsening of the patient's condition. Close monitoring of patient's condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.
-
Type 1 diabetes mellitus
This medicine is not recommended for use in patients with a known history of type 1 diabetes mellitus since it is not effective in treating this condition.
-
Use in pediatrics
This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established.
Dosage
-
Missed Dose
Take the missed dose as soon as you remember it. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.
-
Overdose
Seek emergency medical treatment or contact the doctor in case of an overdose.
-
severe
This medicine should be used with extreme caution in patients with a known history of pancreatitis due to the increased risk of recurrent pancreatitis. Report any symptoms such as abdominal pain, nausea, vomiting, etc. to the doctor immediately. Therapy with the medicine may be discontinued based on the clinical condition of the patient.
General Instructions
Take this medicine exactly as instructed by the doctor. It can be taken with or without food. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Do not stop the use of this medicine without consulting your doctor.
Other details
- Can be taken with or without food, as advised by your doctor
- To be taken as instructed by doctor
- Does not cause sleepiness
References
- medlineplus - Linagliptin [Internet]. Available from: https://medlineplus.gov/druginfo/meds/a611036.html [cited 2/6/2021]. 2021
One of the following licensed pharmacy from the nearest location will deliver TRAJENTA TABLET 5MG ( LINAGLIPTIN ). The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.
Questions and Answers
There are no questions yet. Be the first to ask a question about this product.
6 reviews for TRAJENTA TABLET 5MG ( LINAGLIPTIN )
Ali Bin Arshad (verified owner) –
Ali Bin Arshad submitted 5 stars.
Tassawar Hussain –
Tassawar Hussain submitted 5 stars.
Salahuddin Babur –
Salahuddin Babur submitted 4 stars.
safoora kousar –
safoora kousar submitted 5 stars.
kashif Riaz –
kashif Riaz submitted 5 stars.
Sami Uddin (verified owner) –
Sami Uddin submitted 5 stars.